Increased 3-Nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation

Annals of Neurology

Volumn 42, Issue 3, 1997, Pages 326-334

  Ferrante, Robert J ^a,c   Shinobu, Leslie A ^b   Schulz, Jörg B ^c   Matthews, Russell T ^b   Thomas, Craig E ^d   Kowall, Neil W ^e   Gurney, Mark E ^f   Flint Beal, M ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d SANOFI   (France)

^e PFIZER INC   (United States)

^f UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; COPPER ZINC SUPEROXIDE DISMUTASE; HEME OXYGENASE; HYDROXYL RADICAL; MALONALDEHYDE; PEROXYNITRITE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN CORTEX; CELL LOSS; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; LIPID PEROXIDATION; MOTOR NEURON DISEASE; NITRATION; NONHUMAN; OXIDATIVE STRESS; PARALYSIS; POINT MUTATION; PRIORITY JOURNAL; SPINAL CORD; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; COPPER; HEME OXYGENASE (DECYCLIZING); HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MOTOR NEURON DISEASE; POINT MUTATION; PROTEIN BINDING; SPINAL CORD; SUPEROXIDE DISMUTASE; TYROSINE; ZINC;

EID: 0030767498     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420309     Document Type: Article

References (43)

1. Price DL, Cleveland DW, Koliatsos VE. Motor neuron disease and animal models. Neurobiol Dis 1994;1:3-11
2. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993:362:59-62
3. Bowling AC, Barkowski EE, McKenna-Yasek D, et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 1995:64:2366-2369
4. Reaume AG, Elliott JL, Huffman EK, et al. Motor neurons in Cu/Zn Superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996:13:43-47
5. Brown RH Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995:80:687-692
6. Gurney ME, Chiu AY, Dal Canto MC, et al. Motor neuron degeneration in mice that express a human Cu.Zn Superoxide dismutase mutation. Science 1994;264:1772-1775
7. Ripps ME, Huntley GW, Hof PR, et al. Transgenic mice expressing an altered murine Superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sei USA 1995:92:689-693
8. Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995:14:1105-1116
9. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu.Zn Superoxide dismutase. Science 1993:261:1047-1051
10. Lyons TJ, Liu H, Goto JJ, et al. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc Natl Acad Sei USA 1996:93:12240-12244
11. Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-518
12. Yim MB, Kang J-H, Yim H-S, et al. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu.Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sei USA 1996:93:5709-5714
13. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993:364:584 (Letter)
14. Beckman JS, Ischiropoulos H, Zhu L, et al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys 1992:298:438-445
15. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by Superoxide dismutase. Arch Biochem Biophys 1992:298:431-437
16. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994;l45:12711280
17. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu.Zn SOD, and in mice overexpressing wild rype human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995:676:25-40
18. Béai MF, Maison WR, Swartz KJ, et al. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem 1990;55: 1327-1339
19. Schulz JB, Matthews RT, Jenkins BG, et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 1995:15:8419-8429
20. Chirico S. High-performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol 1994:223:314-318
21. Ferrante RJ, Kowall NW, Cipolloni PB, et al. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neutochemical characterization. Exp Neurol 1993:119:46-71
22. Tu P-H, Raju P, Robinson KA, et al. Transgenic mice carrying a human mutant Superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sei USA 1996:93:31553160
23. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sei USA 1990:87:1620-1624
24. van der Vliet A, O'Neill CA, Halliwell B, et al. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite. FEES Lett 1994:339:89-92
25. Schulz JB, Matthews RT, Muqit MMK, et al. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP induced neurotoxicity in mice. J Neurochem 1995:64:936-939
26. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sei 1990;15:129-135
27. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993:57:7155725S
28. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996:39:147-157
29. Dwyer BE, Nishimura RN, Lu S-Y. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Mol Brain Res 1995:30:37-47
30. Fukuda K, Panter SS, Sharp FR, Noble LJ. Induction of heme oxygenase-1 (HO-1) after traumatic brain injury in the rat. Neurosci Lett 1995:199:127-130
31. Kutty RK, Kutty G, Wiggert B, et al. Induction of heme oxygenase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sei USA 1995:92:1177-1181
32. Kong S-K, Yim MB, Stadtman ER, Chock PB. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc Natl Acad Sei USA 1996; 93:3377-3382
33. Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994:13:975-988
34. Figlewicz DA, Krizus A, Martinoli MG, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3:1757-1761
35. Troncoso JC, Costello AC, Kirn JH, Johnson GVW. Metalcatalyzed oxidation of bovine neurofilaments in vitro. Free Radie Biol Med 1995:18:891-899
36. Collard J-F, Cote F, Julien J-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995:375:61-64
37. Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 1996;47:535-540
38. Abe K, Pan L-H, Watanabe M, et al. Induction of nitrotyrosinelike immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett 1995:199:152-154
39. Béai MF, Ferrante RJ, Matthews RT, et al. 3-Nitrotyrosine in ALS. Soc Neurosci Abstr 1996:22:1943 (Abstract)
40. Chou SM, Wang HS, Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat 1996;10:249-258
41. Chou SM, Wang HS, Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregatin in ALS/ MND. J Neurol Sei 1996:139:16-26
42. Dugan LL, Turetsky DM, Du C, et al. Carboxybuckminsterfullerenes: novel antioxidants with neuroprotective efficacy in vitro and in a mouse model of ALS. Soc Neurosci Abstr 1996:22:2142 (Abstract)
43. Sasaki M, Facchinetti F, Christov V, et al. Is neuronal nitric oxide synthase involved in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Soc Neurosci Abstr 1996;22:2142 (Abstract)